Dabrafenib plus trametinib in BRAF K601E-mutant melanoma

Br J Dermatol. 2019 Feb;180(2):421-422. doi: 10.1111/bjd.17250. Epub 2018 Nov 22.

A Rogiers^{1

2}, D Thomas³, S Vander Borght^{4

5}, J J van den Oord⁵, O Bechter⁶, M Dewaele^{1

2}, F Rambow^{1

2}, J-C Marine^{1

2}, P Wolter⁷

¹ Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium.
² Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
³ Laboratory for Therapeutic and Diagnostic Antibodies/PharmAbs, KU Leuven, Leuven, Belgium.
⁴ Department of Human Genetics, Center for Human Genetics, KU Leuven, Leuven, Belgium.
⁵ Department of Pathology, University Hospitals, KU Leuven, Leuven, Belgium.
⁶ Department of General Medical Oncology, KU Leuven, Leuven, Belgium.
⁷ Department of Hematology and Medical Oncology, CHR East Belgium, Verviers, Belgium.

No abstract available

Publication types